Detalhe da pesquisa
1.
Glycolytic metabolism of pathogenic T cells enables early detection of GVHD by 13C-MRI.
Blood
; 137(1): 126-137, 2021 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32785680
2.
A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease.
Blood
; 137(7): 896-907, 2021 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32976576
3.
The clinical landscape of chronic graft-versus-host disease management in 2021.
Br J Haematol
; 196(4): 830-848, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34599519
4.
Collection of peripheral blood mononucleated cells for chronic graft-versus-host disease immunology research: safety and effectiveness of leukapheresis in 132 patients.
J Transl Med
; 20(1): 519, 2022 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36348353
5.
Long-term follow-up after lymphodepleting autologous haematopoietic cell transplantation for treatment-resistant systemic lupus erythematosus.
Rheumatology (Oxford)
; 61(8): 3317-3328, 2022 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34875023
6.
Rehabilitation Interventions in the Multidisciplinary Management of Patients With Sclerotic Graft-Versus-Host Disease of the Skin and Fascia.
Arch Phys Med Rehabil
; 102(4): 776-788, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33347890
7.
B regulatory cells and monocyte subpopulations in patients with chronic graft-vs-host disease.
Croat Med J
; 62(2): 154-164, 2021 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33938655
8.
W"H-Y" antigen/HLA complexes in chronic GVHD.
Blood
; 142(11): 946-948, 2023 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37707875
9.
Introduction to a review series on emerging immunotherapies for hematologic diseases.
Blood
; 131(24): 2617-2620, 2018 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29728405
10.
Clinical characteristics and cytokine biomarkers in patients with chronic graft-vs-host disease persisting seven or more years after diagnosis.
Am J Hematol
; 95(4): 387-394, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31903638
11.
Motor ability, function, and health-related quality of life as correlates of symptom burden in patients with sclerotic chronic graft-versus-host disease receiving imatinib mesylate.
Support Care Cancer
; 28(8): 3679-3689, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31811481
12.
Cytomegalovirus Infection Incidence and Risk Factors Across Diverse Hematopoietic Cell Transplantation Platforms Using a Standardized Monitoring and Treatment Approach: A Comprehensive Evaluation from a Single Institution.
Biol Blood Marrow Transplant
; 25(3): 577-586, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30342913
13.
Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.
Biol Blood Marrow Transplant
; 25(12): 2305-2321, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31446199
14.
Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 25(3): e76-e85, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30576834
15.
An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD.
Blood
; 130(19): 2131-2145, 2017 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28851699
16.
Red cell distribution width as a new prognostic biomarker in refractory chronic graft-versus-host disease.
Haematologica
; 109(1): 298-302, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37584292
17.
Impaired Bone Mineral Density in Pediatric Patients with Chronic Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 24(7): 1415-1423, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29496562
18.
Steroid Refractory Chronic Graft-Versus-Host Disease: Cost-Effectiveness Analysis.
Biol Blood Marrow Transplant
; 24(9): 1920-1927, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29550629
19.
Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host disease.
Blood
; 127(1): 160-6, 2016 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26527676
20.
Durable discontinuation of systemic therapy for chronic graft-versus-host disease: myth or reality?
Haematologica
; 108(2): 303-305, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35615928